Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Operating Leases (2019 - 2024)

Historic Operating Leases for CureVac (CVAC) over the last 6 years, with Q4 2024 value amounting to $41.6 million.

  • CureVac's Operating Leases fell 747.17% to $41.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.6 million, marking a year-over-year decrease of 747.17%. This contributed to the annual value of $41.6 million for FY2024, which is 747.17% down from last year.
  • CureVac's Operating Leases amounted to $41.6 million in Q4 2024, which was down 747.17% from $99805.9 recorded in Q2 2024.
  • CureVac's Operating Leases' 5-year high stood at $45.0 million during Q4 2023, with a 5-year trough of -$126637.9 in Q1 2021.
  • In the last 5 years, CureVac's Operating Leases had a median value of $100684.0 in 2024 and averaged $18.1 million.
  • Per our database at Business Quant, CureVac's Operating Leases tumbled by 786.34% in 2021 and then skyrocketed by 48680.57% in 2024.
  • Quarter analysis of 5 years shows CureVac's Operating Leases stood at $35.9 million in 2020, then decreased by 7.86% to $33.1 million in 2021, then rose by 29.91% to $42.9 million in 2022, then increased by 4.8% to $45.0 million in 2023, then decreased by 7.47% to $41.6 million in 2024.
  • Its Operating Leases was $41.6 million in Q4 2024, compared to $99805.9 in Q2 2024 and $100684.0 in Q1 2024.